Guideline

The goal of this document is to provide practical answers to ethical questions in regard to the End TB Strategy.

These guidelines contain policy recommendations on priority areas in the treatment of drug-susceptible TB and patient care.

This guideline presents updated data about drug interactions between protease inhibitors and non-nucleoside reverse transcriptase inhibitors for treatment of HIV infection together with rifamycins for treatment of TB.

The Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007 updates and expands the 1996 Guideline for Isolation Precautions in Hospitals.

The purpose of this document is to examine the different parameters necessary for an effec­tive upper-room ultraviolet germicidal irradiation (UVGI) system and to provide guidelines to healthcare managers, facility designers, engineers, and industrial hygienists on the parameters necessary to install and maintain an effective upper-room UVGI system.

This Guide describes how to make TB services 100% tobacco-free, then presents ‘ABC for TB’, an intervention for TB programmes to help patients quit smoking and to promote smokefree homes for patients and families. It advocates keeping cessation simple, expanding it widely through the health services and reaching communities. ‘ABC for TB’ does not require specialised staff, clinics or medicines. It is delivered systematically within routine programme activities and can be done within as little as 2-5 minutes. It includes recording and monitoring processes and outcomes.

This handbook is a reference tool for use by national tuberculosis (TB) program managers, clinicians and nurses, public health decision-makers and technical and implementing partners committed to the prevention, care, diagnosis and treatment of drug-resistant TB.

This monograph provides information for use by tribal, state, and local public health practitioners and their legal counsel to help improve their understanding and use of relevant laws to respond to challenges concerning TB control. Part I of the monograph contains an introduction and table listing resources on communicable disease and TB control methods in selected US jurisdictions. Part II presents a brief overview of some of the essential components of TB control, including a discussion of the international and national threats of the disease and modern public health interventions.

This serial presents updated guidelines to US public health officials, healthcare providers, and laboratory workers for use of FDA-approved interferon gamma release assays (IGRAs) to diagnose both active and latent TB infection in adults and children. These guidelines include use of the QuantiFERON-TB Gold In-Tube Test (QFT-GIT) and the T-SPOT.TB Test (T-Spot), two new IGRAs that were not included in the previous guidelines published in 2005. The antigens, methods, and interpretation criteria for these assays differ from those for IGRAs approved previously.